{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:48:25Z","timestamp":1789386505224,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.annder.2010.08.015","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T04:53:39Z","timestamp":1285908819000},"page":"730-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["N\u00e9croses cutan\u00e9es localis\u00e9es aux points d\u2019injection d\u2019apomorphine"],"prefix":"10.1016","volume":"137","author":[{"given":"A.","family":"Dadban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-S.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Portet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a04","key":"10.1016\/j.annder.2010.08.015_bib0005","first-page":"S8","article-title":"Subcutaneously administered apomorphine: pharmacokinetics and metabolism","volume":"62","author":"LeWitt","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2010.08.015_bib0010","first-page":"315","article-title":"Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox","volume":"142","author":"Ugwoke","year":"2003","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.annder.2010.08.015_bib0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp.64.5.573","article-title":"Continuous subcutaneous waking day apomorphine in the long-term treatment of levodopa induced interdose dyskinesias in Parkinson's disease","volume":"64","author":"Colzi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annder.2010.08.015_bib0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.20852","article-title":"Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease","volume":"21","author":"Garcia Ruiz","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.annder.2010.08.015_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(88)91193-2","article-title":"Subcutaneous apomorphine in parkinsonian on-off oscillations","volume":"1","author":"Stibe","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2010.08.015_bib0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0035-3787(06)75115-3","article-title":"L\u2019apomorphine en perfusion continue dans la maladie de Parkinson","volume":"162","author":"Drapier","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.annder.2010.08.015_bib0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneur.58.9.1385","article-title":"A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events","volume":"58","author":"Dewey","year":"2001","journal-title":"Arch Neurol"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.annder.2010.08.015_bib0040","first-page":"S32","article-title":"Practical considerations in the use of apomorphine injectable","volume":"62","author":"Bowron","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2010.08.015_bib0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jnnp.65.5.709","article-title":"Subcutaneous apomorphine in late stage Parkinson's disease: a long-term follow-up","volume":"65","author":"Pietz","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annder.2010.08.015_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mds.870130113","article-title":"The role of EDTA in provoking allergic re actions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study","volume":"13","author":"van Laar","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.annder.2010.08.015_bib0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2133.1998.02128.x","article-title":"Panniculitis in association with apomorphine infusion","volume":"138","author":"Acland","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2010.08.015_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/01.WNL.0000149757.47854.6F","article-title":"Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease","volume":"64","author":"Pot","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2010.08.015_bib0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.12968\/bjcn.2008.13.10.31182","article-title":"Apomorphine nodules in Parkinson's disease: best practice considerations","volume":"13","author":"Todd","year":"2008","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.annder.2010.08.015_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mds.22316","article-title":"Ultrsound treatment of cutaneous side-effects of infused apomophine: a randomized controlled pilot study","volume":"24","author":"Poltawski","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.annder.2010.08.015_bib0075","first-page":"58","article-title":"Apomorphin-Pigmentierung","volume":"54","author":"Loewe","year":"2003","journal-title":"Hautarzt"},{"key":"10.1016\/j.annder.2010.08.015_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0536.1997.tb00417.x","article-title":"Allergic contact dermatitis from apomorphine","volume":"36","author":"Carboni","year":"1997","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.annder.2010.08.015_bib0085","first-page":"702","article-title":"Nasolabial allergic reaction to intranasal administration of apomorphine in Parkinson's disease","volume":"136","author":"van Laar","year":"1992","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.annder.2010.08.015_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mds.20716","article-title":"Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine","volume":"21","author":"Tackenberg","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.annder.2010.08.015_bib0095","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-004-0547-4","article-title":"A 10-year retrospective audit of long-term apomorphine use in Parkinson's disease","volume":"251","author":"Hilary","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.annder.2010.08.015_bib0100","first-page":"145","article-title":"The peripheral dopaminergic system: morphological analysis, functional and clinical applications","volume":"107","author":"Amenta","year":"2002","journal-title":"Ital J Anat Embryol"},{"key":"10.1016\/j.annder.2010.08.015_bib0105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/mds.10281","article-title":"Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64\u00a0patients","volume":"17","author":"Manson","year":"2002","journal-title":"Mov Disord"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810003650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810003650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:57:09Z","timestamp":1758970629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963810003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0151963810003650"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2010.08.015","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9croses cutan\u00e9es localis\u00e9es aux points d\u2019injection d\u2019apomorphine","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2010.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}